"Designing Growth Strategies is in our DNA"

Precision Medicine Market Size, Share & Industry Analysis, By Product (Drugs, Devices, Software), By Type (Diagnostic {Genetic Tests [Predictive & Presymptomatic Tests, Carrier Testing, Prenatal & Newborn Screening], Biomarker Tests [Screening, Recurrence Monitoring, & Therapy Selection]}, Therapeutics {Monoclonal Antibodies, Gene Therapy, Cell Therapy}, & Research), By Indication (Oncology, Neurology/ Psychiatry, Immunology), By End-User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations), & Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI110463

 

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Chronic Diseases, By Key Countries/ Regions, 2023
    2. Percentage of FDA Approved Precision Medicine Drugs, 2019-2023
    3. New Product Launches/ Approvals, By Key Players
    4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    5. Pipeline Analysis
    6. Impact of COVID-19 in the Market
  5. Global Precision Medicine Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Software
    2. Market Analysis, Insights and Forecast – By Type
      1. Diagnostic
        1. Genetic Tests
          1. Predictive & Presymptomatic Tests
          2. Carrier Testing
          3. Prenatal & Newborn Screening
          4. Others
        2. Biomarker Tests
          1. Screening
          2. Recurrence Monitoring
          3. Therapy Selection
        3. Others
      2. Therapeutics
        1. Monoclonal Antibodies
        2. Gene Therapy
        3. Cell Therapy
        4. Others
      3. Research
    3. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Neurology/ Psychiatry
      3. Immunology
      4. Cardiology
      5. Endocrinology
      6. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biopharmaceutical Companies
      2. Diagnostic Laboratories
      3. Contract Research Organizations (CROs)
      4. Others
    5. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Precision Medicine Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Software
    2. Market Analysis, Insights and Forecast – By Type
      1. Diagnostic
        1. Genetic Tests
          1. Predictive & Presymptomatic Tests
          2. Carrier Testing
          3. Prenatal & Newborn Screening
          4. Others
        2. Biomarker Tests
          1. Screening
          2. Recurrence Monitoring
          3. Therapy Selection
        3. Others
      2. Therapeutics
        1. Monoclonal Antibodies
        2. Gene Therapy
        3. Cell Therapy
        4. Others
      3. Research
    3. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Neurology/ Psychiatry
      3. Immunology
      4. Cardiology
      5. Endocrinology
      6. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biopharmaceutical Companies
      2. Diagnostic Laboratories
      3. Contract Research Organizations (CROs)
      4. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Precision Medicine Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Software
    2. Market Analysis, Insights and Forecast – By Type
      1. Diagnostic
        1. Genetic Tests
          1. Predictive & Presymptomatic Tests
          2. Carrier Testing
          3. Prenatal & Newborn Screening
          4. Others
        2. Biomarker Tests
          1. Screening
          2. Recurrence Monitoring
          3. Therapy Selection
        3. Others
      2. Therapeutics
        1. Monoclonal Antibodies
        2. Gene Therapy
        3. Cell Therapy
        4. Others
      3. Research
    3. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Neurology/ Psychiatry
      3. Immunology
      4. Cardiology
      5. Endocrinology
      6. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biopharmaceutical Companies
      2. Diagnostic Laboratories
      3. Contract Research Organizations (CROs)
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K 
      2. Germany 
      3. France
      4. Spain 
      5. Italy
      6. Scandinavia
      7. Rest of Europe 
  8. Asia Pacific Precision Medicine Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Software
    2. Market Analysis, Insights and Forecast – By Type
      1. Diagnostic
        1. Genetic Tests
          1. Predictive & Presymptomatic Tests
          2. Carrier Testing
          3. Prenatal & Newborn Screening
          4. Others
        2. Biomarker Tests
          1. Screening
          2. Recurrence Monitoring
          3. Therapy Selection
        3. Others
      2. Therapeutics
        1. Monoclonal Antibodies
        2. Gene Therapy
        3. Cell Therapy
        4. Others
      3. Research
    3. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Neurology/ Psychiatry
      3. Immunology
      4. Cardiology
      5. Endocrinology
      6. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biopharmaceutical Companies
      2. Diagnostic Laboratories
      3. Contract Research Organizations (CROs)
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan 
      2. China 
      3. India
      4. Australia
      5. South East Asia
      6. Rest of Asia Pacific
  9. Latin America Precision Medicine Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Software
    2. Market Analysis, Insights and Forecast – By Type
      1. Diagnostic
        1. Genetic Tests
          1. Predictive & Presymptomatic Tests
          2. Carrier Testing
          3. Prenatal & Newborn Screening
          4. Others
        2. Biomarker Tests
          1. Screening
          2. Recurrence Monitoring
          3. Therapy Selection
        3. Others
      2. Therapeutics
        1. Monoclonal Antibodies
        2. Gene Therapy
        3. Cell Therapy
        4. Others
      3. Research
    3. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Neurology/ Psychiatry
      3. Immunology
      4. Cardiology
      5. Endocrinology
      6. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biopharmaceutical Companies
      2. Diagnostic Laboratories
      3. Contract Research Organizations (CROs)
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa  Precision Medicine Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Drugs
      2. Devices
      3. Software
    2. Market Analysis, Insights and Forecast – By Type
      1. Diagnostic
        1. Genetic Tests
          1. Predictive & Presymptomatic Tests
          2. Carrier Testing
          3. Prenatal & Newborn Screening
          4. Others
        2. Biomarker Tests
          1. Screening
          2. Recurrence Monitoring
          3. Therapy Selection
        3. Others
      2. Therapeutics
        1. Monoclonal Antibodies
        2. Gene Therapy
        3. Cell Therapy
        4. Others
      3. Research
    3. Market Analysis, Insights and Forecast – By Indication
      1. Oncology
      2. Neurology/ Psychiatry
      3. Immunology
      4. Cardiology
      5. Endocrinology
      6. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Pharmaceutical & Biopharmaceutical Companies
      2. Diagnostic Laboratories
      3. Contract Research Organizations (CROs)
      4. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. Illumina, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Agilent Technologies, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Bristol-Myers Squibb Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Nucleai, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Precision Medicine Group, LLC.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. AstraZeneca
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. QIAGEN
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. Abbott
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      12. Koninklijke Philips N.V.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      13. IBM Life Sciences
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Precision Medicine Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 2: Global Precision Medicine Market Value Share (%), by Product, 2023 & 2032

Figure 3: Global Precision Medicine Market Value Share (%), by Type, 2023 & 2032

Figure 4: Global Precision Medicine Market Value Share (%), by Indication, 2023 & 2032

Figure 5: Global Precision Medicine Market Value Share (%), by End User, 2023 & 2032

Figure 6: Global Precision Medicine Market Value (USD billion), by Region, 2023 & 2032

Figure 7: North America Precision Medicine Market Value (USD billion), by Product, 2023 & 2032

Figure 8: North America Precision Medicine Market Value Share (%), by Product, 2023

Figure 9: North America Precision Medicine Market Value (USD billion), by Type, 2023 & 2032

Figure 10: North America Precision Medicine Market Value Share (%), by Type, 2023

Figure 11: North America Precision Medicine Market Value (USD billion), by Indication, 2023 & 2032

Figure 12: North America Precision Medicine Market Value Share (%), by Indication, 2023

Figure 13: North America Precision Medicine Market Value (USD billion), by End User, 2023 & 2032

Figure 14: North America Precision Medicine Market Value Share (%), by End User, 2023

Figure 15: North America Precision Medicine Market Value (USD billion), By Country, 2023 & 2032

Figure 16: North America Precision Medicine Market Value Share (%), By Country, 2023

Figure 17: Europe Precision Medicine Market Value (USD billion), by Product, 2023 & 2032

Figure 18: Europe Precision Medicine Market Value Share (%), by Product, 2023

Figure 19: Europe Precision Medicine Market Value (USD billion), by Type, 2023 & 2032

Figure 20: Europe Precision Medicine Market Value Share (%), by Type, 2023

Figure 21: Europe Precision Medicine Market Value (USD billion), by Indication, 2023 & 2032

Figure 22: Europe Precision Medicine Market Value Share (%), by Indication, 2023

Figure 23: Europe Precision Medicine Market Value (USD billion), by End User, 2023 & 2032

Figure 24: Europe Precision Medicine Market Value Share (%), by End User, 2023

Figure 25: Europe Precision Medicine Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 26: Europe Precision Medicine Market Value Share (%), By Country/ Sub-region, 2023

Figure 27: Asia Pacific Precision Medicine Market Value (USD billion), by Product, 2023 & 2032

Figure 28: Asia Pacific Precision Medicine Market Value Share (%), by Product, 2023

Figure 29: Asia Pacific Precision Medicine Market Value (USD billion), by Type, 2023 & 2032

Figure 30: Asia Pacific Precision Medicine Market Value Share (%), by Type, 2023

Figure 31: Asia Pacific Precision Medicine Market Value (USD billion), by Indication, 2023 & 2032

Figure 32: Asia Pacific Precision Medicine Market Value Share (%), by Indication, 2023

Figure 33: Asia Pacific Precision Medicine Market Value (USD billion), by End User, 2023 & 2032

Figure 34: Asia Pacific Precision Medicine Market Value Share (%), by End User, 2023

Figure 35: Asia Pacific Precision Medicine Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 36: Asia Pacific Precision Medicine Market Value Share (%), By Country/ Sub-region, 2023

Figure 37: Latin America Precision Medicine Market Value (USD billion), by Product, 2023 & 2032

Figure 38: Latin America Precision Medicine Market Value Share (%), by Product, 2023

Figure 39: Latin America Precision Medicine Market Value (USD billion), by Type, 2023 & 2032

Figure 40: Latin America Precision Medicine Market Value Share (%), by Type, 2023

Figure 41: Latin America Precision Medicine Market Value (USD billion), by Indication, 2023 & 2032

Figure 42: Latin America Precision Medicine Market Value Share (%), by Indication, 2023

Figure 43: Latin America Precision Medicine Market Value (USD billion), by End User, 2023 & 2032

Figure 44: Latin America Precision Medicine Market Value Share (%), by End User, 2023

Figure 45: Latin America Precision Medicine Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 46: Latin America Precision Medicine Market Value Share (%), By Country/ Sub-region, 2023

Figure 47: Middle East & Africa Precision Medicine Market Value (USD billion), by Product, 2023 & 2032

Figure 48: Middle East & Africa Precision Medicine Market Value Share (%), by Product, 2023

Figure 49: Middle East & Africa Precision Medicine Market Value (USD billion), by Type, 2023 & 2032

Figure 50: Middle East & Africa Precision Medicine Market Value Share (%), by Type, 2023

Figure 51: Middle East & Africa Precision Medicine Market Value (USD billion), by Indication, 2023 & 2032

Figure 52: Middle East & Africa Precision Medicine Market Value Share (%), by Indication, 2023

Figure 53: Middle East & Africa Precision Medicine Market Value (USD billion), by End User, 2023 & 2032

Figure 54: Middle East & Africa Precision Medicine Market Value Share (%), by End User, 2023

Figure 55: Middle East & Africa Precision Medicine Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 56: Middle East & Africa Precision Medicine Market Value Share (%), By Country/ Sub-region, 2023

Figure 57: Global Precision Medicine Market Share (%), By Company, 2023

Table 1: Global Precision Medicine Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 2: Global Precision Medicine Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 3: Global Precision Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2019-2032

Table 4: Global Precision Medicine Market Revenue (USD billion) Forecast, by Biomarker Test, 2019-2032

Table 5: Global Precision Medicine Market Revenue (USD billion) Forecast, by Genetic Test, 2019-2032

Table 6: Global Precision Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2019-2032

Table 7: Global Precision Medicine Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 8: Global Precision Medicine Market Revenue (USD billion) Forecast, by End User, 2019–2032

Table 9: Global Precision Medicine Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 10: North America Precision Medicine Market Revenue (USD billion) Forecast, by Product, 2019-2032

Table 11: North America Precision Medicine Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 12: North America Precision Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2019-2032

Table 13: North America Precision Medicine Market Revenue (USD billion) Forecast, by Biomarker Test, 2019-2032

Table 14: North America Precision Medicine Market Revenue (USD billion) Forecast, by Genetic Test, 2019-2032

Table 15: North America Precision Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2019-2032

Table 16: North America Precision Medicine Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 17: North America Precision Medicine Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 18: North America Precision Medicine Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 19: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Product, 2019-2032

Table 20: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 21: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2019-2032

Table 22: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Biomarker Test, 2019-2032

Table 23: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Genetic Test, 2019-2032

Table 24: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2019-2032

Table 25: Europe Precision Medicine Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 26: Europe Precision Medicine Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 27: Europe Precision Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 28: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Product, 2019-2032

Table 29: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 30: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2019-2032

Table 31: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Biomarker Test, 2019-2032

Table 32: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Genetic Test, 2019-2032

Table 33: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2019-2032

Table 34: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 35: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 36: Asia Pacific Precision Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 37: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Product, 2019-2032

Table 38: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 39: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2019-2032

Table 40: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Biomarker Test, 2019-2032

Table 41: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Genetic Test, 2019-2032

Table 42: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2019-2032

Table 43: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 44: Latin America Precision Medicine Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 45: Latin America Precision Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 46: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Product, 2019-2032

Table 47: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 48: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Diagnostics, 2019-2032

Table 49: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Biomarker Test, 2019-2032

Table 50: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Genetic Test, 2019-2032

Table 51: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Therapeutics, 2019-2032

Table 52: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 53: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, by End User, 2019-2032

Table 54: Middle East & Africa Precision Medicine Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Precision Medicine Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 181
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann